Average Co-Inventor Count = 4.11
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Scifluor Life Sciences, Inc. (8 from 23 patents)
2. Merck Sharp + Dohme Corp. (4 from 2,405 patents)
3. Preceres Inc. (3 from 3 patents)
4. Merck + Co., Inc. (1 from 4,770 patents)
5. Ocuterra Therapeutics, Inc. (1 from 5 patents)
17 patents:
1. 11685737 - Fluorinated integrin antagonists
2. 10155758 - Fluorinated 3-(2-oxo-3-(3-arylpropyl)imidazolidin-1-yl)-3-arylpropanoic acid derivatives
3. 10106537 - Fluorinated integrin antagonists
4. 9802933 - Fluorinated 3-(2-oxo-3-(3-arylpropyl)imidazolidin-1-yl)-3-arylpropanoic acid derivatives
5. 9717729 - Fluorinated integrin antagonists
6. 9593114 - Fluorinated 3-(2-oxo-3-(3-arylpropyl)imidazolidin-1-yl)-3-arylpropanoic acid derivatives
7. 9518053 - Fluorinated integrin antagonists
8. 9409869 - Hydrazinyl lipidoids and uses thereof
9. 9363992 - Hydrazinyl lipidoids and uses thereof
10. 9339029 - Hydrazinyl lipidoids and uses thereof
11. 9266884 - Fluorinated 3-(2-oxo-3-(3-arylpropyl)imidazolidin-1-y1)-3-arylpropanoic acid derivatives
12. 8901144 - Fluorinated 3-(2-oxo-3-(3-arylpropyl)imidazolidin-1-yl)-3-arylpropanoic acid derivatives
13. 8871796 - Diaryl ether derivatives as notch sparing gamma secretase inhibitors
14. 8759579 - Cyclobutyl sulfones as notch sparing gamma secretase inhibitors
15. 8119685 - Disubstituted aniline compounds